2019...• normal prostate: anatomy – embryology, histology • prostate cancer: epidemiology and...

2
ROADMAP 2019 MULTIMODAL CANCER TREATMENT RADIATION ONCOLOGIST, OTHER SPECIALIST Multidisciplinary management of prostate cancer 19-23 May 2019 | Pisa, Italy This interactive, multi- disciplinary and state-of-the art course on prostate cancer provides in-depth knowledge of the disease and its management, as well as an overview of the latest imaging and treatment techniques and drugs. TARGET GROUP e course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge. COURSE AIM is 5-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. is will be illustrated during state-oſthe-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course. LEARNING OUTCOMES • To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer To discuss patient selection/indications and contra-indications for the various treatment options To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease To debate on the most recent developments relevant to prostate cancer management. COURSE CONTENT • Normal prostate: anatomy – embryology, histology • Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging Low risk prostate cancer: active surveillance, surgery and the postop pathology • Radiotherapy and brachytherapy, the pathology aſter irradiation External beam radiotherapy: on-line control, target delineation High risk prostate cancer: radiotherapy and hormones, alternative radiotherapy regimens • Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction Role of surgery and its morbidity • Alternative treatments • Adjuvant and salvage radiotherapy aſter radical surgery • Rising PSA after surgery and after radiotherapy • Imaging for recurrent detection • Node positive prostate cancer • Metastatic prostate cancer: hormones and their complications COURSE DIRECTOR Alberto Bossi (FR) CO-CHAIR Alberto Briganti (IT) TEACHERS Ferran Algaba (ES) Valerie Fonteyne (BE) Nicolas Mottet (FR) Alfonso Gomez de Iturriaga (ES) Geert Villeirs (BE) Jochen Walz (FR) DELINEATION ADMINISTRATOR Berardino de Bari (FR) LOCAL ORGANISERS Fabiola Paiar & Francesco Pasqualetti, University of Pisa - Azienda Ospedaliero Universitaria Pisana, Pisa (IT) [email protected] PROJECT MANAGER Säde Sfakiotakis, ESTRO Office (BE) WORKING SCHEDULE The course starts on 19 May 2019 at 09:00 and ends on 23 May 2019 at 13:00. LANGUAGE The course is conducted in English. No simultaneous translation will be provided. COURSE ORGANISATION For any further information please contact ESTRO: Säde Sfakiotakis E-mail: [email protected] Tel : +32 2 775 93 32 Fax : +32 2 779 54 94 ACCOMMODATION More detailed information about accommodation will be available soon on the ESTRO website: www.estro.org/school COURSE VENUE Aula Magna Polo Fibonacci Largo Bruno Pontecorvo 3, 56127 Pisa, Italy www.unipi.it/index.php/unipieventi/Luogo/132-aula- magna-polo-fibonacci TECHNICAL EXHIBITION Companies interested in exhibition opportunities during this teaching course should contact ESTRO: Säde Sfakiotakis E-mail: [email protected] Tel : +32 2 775 93 32 Fax : +32 2 779 54 94

Upload: others

Post on 31-May-2020

6 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 2019...• Normal prostate: anatomy – embryology, histology • Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging • Low risk

ROADMAP

2019

MULTIMODAL CANCER TREATMENT

RADIATION ONCOLOGIST, OTHER SPECIALIST

Multidisciplinary management of prostate cancer19-23 May 2019 | Pisa, Italy

This interactive, multi-disciplinary and state-of-the art course on prostate cancer provides in-depth knowledge of the disease and its management, as well as an overview of the latest imaging and treatment techniques and drugs.

TARGET GROUPThe course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge.

COURSE AIMThis 5-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-ofthe-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course.

LEARNING OUTCOMES • To provide an in-depth overview of the

epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer

• To discuss patient selection/indications and contra-indications for the various treatment options

• To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer

• To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease

• To debate on the most recent developments relevant to prostate cancer management.

COURSE CONTENT • Normal prostate: anatomy – embryology,

histology• Prostate cancer: epidemiology and

prevention, clinical diagnosis, imaging modalities pathology, staging

• Low risk prostate cancer: active surveillance, surgery and the postop pathology

• Radiotherapy and brachytherapy, the pathology after irradiation

• External beam radiotherapy: on-line control, target delineation

• High risk prostate cancer: radiotherapy and hormones, alternative radiotherapy regimens

• Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction

• Role of surgery and its morbidity• Alternative treatments• Adjuvant and salvage radiotherapy after

radical surgery• Rising PSA after surgery and after

radiotherapy• Imaging for recurrent detection• Node positive prostate cancer• Metastatic prostate cancer: hormones and

their complications

COURSE DIRECTORAlberto Bossi (FR)

CO-CHAIR Alberto Briganti (IT)

TEACHERSFerran Algaba (ES)Valerie Fonteyne (BE)Nicolas Mottet (FR)Alfonso Gomez de Iturriaga (ES)Geert Villeirs (BE)Jochen Walz (FR)

DELINEATION ADMINISTRATORBerardino de Bari (FR)

LOCAL ORGANISERSFabiola Paiar & Francesco Pasqualetti, University of Pisa - Azienda Ospedaliero Universitaria Pisana, Pisa (IT)[email protected]

PROJECT MANAGER Säde Sfakiotakis, ESTRO Office (BE)

WORKING SCHEDULEThe course starts on 19 May 2019 at 09:00 and ends on 23 May 2019 at 13:00.

LANGUAGEThe course is conducted in English.No simultaneous translation will be provided.

COURSE ORGANISATIONFor any further information please contact ESTRO: Säde SfakiotakisE-mail: [email protected] : +32 2 775 93 32Fax : +32 2 779 54 94

ACCOMMODATIONMore detailed information about accommodation will be available soon on the ESTRO website: www.estro.org/school

COURSE VENUEAula Magna Polo FibonacciLargo Bruno Pontecorvo 3, 56127 Pisa, Italywww.unipi.it/index.php/unipieventi/Luogo/132-aula-magna-polo-fibonacci

TECHNICAL EXHIBITIONCompanies interested in exhibition opportunitiesduring this teaching course should contact ESTRO:Säde SfakiotakisE-mail: [email protected] : +32 2 775 93 32Fax : +32 2 779 54 94

Page 2: 2019...• Normal prostate: anatomy – embryology, histology • Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging • Low risk

WWW.ESTRO.ORG/SCHOOL

These pages offer the guarantee of secured online payments.The system will seamlessly redirect you to the secured website of OGONE (see www.ogone.be for more details) to settle your registration fee.

If online registration is not possible please contact us: ESTRO OFFICERue Martin V, 40 • B-1200 BrusselsTel.: +32 2 775 93 39 • Fax: +32 2 779 54 94E-mail: [email protected]

REGISTRATION FEESPlease check the early deadline date on our website

EARLY FEE LATE FEE

In-training members* 450 € 625 €

Members 600 € 725 €

Non members 750 € 850 €

*Radiation Therapist (RTT) members are eligible for the in-training fee

The fee includes the course material, coffees, lunches, and the social event.

Reduced fees are available for ESTRO members working in eco-nomically less competitive countries. Check the eligible countries and the selection criteria on the website of the ESTRO School.

ESTRO goes green: Please note that the course material will be available online. No course book will be provided during the courses.

ADVANCE REGISTRATION AND PAYMENT ARE REQUIRED.ON-SITE REGISTRATION WILL NOT BE AVAILABLE.Since the number of participants is limited, late registrants are advised to contact the ESTRO office before payment, to inquire about availability of places. Access to homework and/or course material will become available upon receipt of full payment.

INSURANCE AND CANCELLATIONThe organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.

In case an unforeseen event would force ESTRO to cancel the meeting, the Society will reimburse the full registration fees to the participants. ESTRO will not be responsible for the refund of travel and accommodation costs.

In case of cancellation, full refund of the registration fee minus15% for administrative costs may be obtained up to three monthsbefore the course and 50% of the fee up to one month beforethe course. No refund will be made if the cancellation requestis postmarked less than one month before the start of the course.

PARTICIPANTS SHOULD REGISTER ONLINE AT: WWW.ESTRO.ORG/SCHOOL

• Castration resistant prostate cancer: new drugs

• Palliative radiotherapy and surgery• Non systemic treatment in the metastatic

setting.• Care Discussions.

PREREQUISITES Before commencing this course participants should: • Revise the general principles of prostate

cancer epidemiology, pathology, diagnosis and staging

• Read the published ESTRO and ASTRO guidelines on prostate contouring and the

EAU (European Association of Urology) guidelines on prostate cancer

• Complete the FALCON* exercise which is distributed prior to the course.

TEACHING METHODS • 21 hours lectures• 3 hours contouring• 4 hours practical workshops• 5 hours interactive discussions.

The course consists of didactic lectures, interactive sessions (clinical case discussions and Journal Clubs) and practical demonstrations.

METHODS OF ASSESSMENT• MCQ • Delineation exercise • Evaluation form.

KEY WORDSProstate cancer management, Surgery and Radiotherapy.